Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of resultsCaroline Mollévi, Amélie Anota, Hélène de Forges et al.|Quality of Life Research|2020Cited by 18
Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized TrialAntoine Barbieri, Caroline Mollévi, Amélie Anota et al.|Medical Decision Making|2015Cited by 7
Evolution of pain in patients with metastatic pancreatic carcinoma treated with FOLFIRINOX or gemcitabine in a randomized phase III study (ACCORD11/PRODIGE4).Sophie Gourgou, Thierry Conroy, Marta Jarlier et al.|Journal of Clinical Oncology|2015Cited by 0
Mixed-effectsregression Models for longitudinal Analysis of Quality of Life in OncologyAntoine Barbieri, Caroline Mollévi, S. Gourgou-Bourgade et al.|HAL (Le Centre pour la Communication Scientifique Directe)|2014Cited by 0